SMMT

Summit Therapeutics PLC (SMMT)

US
$ 24.290.37%

Price Chart

Key Statistics

Market Cap
$ 18.11B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
3.1M
52W High
$ 36.91
52W Low
$ 2.10
Dividend Yield
0.00%
Beta
-0.95

Technicals

50-Day MA
22.6337
200-Day MA
19.8009
52 Week High
36.91
52 Week Low
2.1

About SMMT

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Employees
159
Headquarters
Miami, FL
CEO
Mr. Robert W. Duggan

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg